Literature DB >> 22997988

Increased fecal calprotectin in preterm infants with necrotizing enterocolitis.

Gokhan Aydemir1, Ferhat Cekmez, I Asya Tanju, Fuat Emre Canpolat, F Alparslan Genc, Sukran Yildirim, Turan Tunc, S Umit Sarici.   

Abstract

BACKGROUND: Necrotizing entrocolitis (NEC) remains a potentially fatal disease in premature infants despite the recent advances in neonatal care. It is a disease with a multifactorial etiology leading to the one common final pathway of necrosis and inflammmation of the neonatal intestine.
METHODS: Calprotectin is a calcium and zinc-binding protein in human neutrophils. Its concentration rises in various organic bowel diseases in adults and is resistant to degradation and has been proposed as a useful, simple, and rapid diagnostic method of inflammatory bowel disease that shows gastrointestinal inflammation in children and adults.
RESULTS: We found that infants with necrotizing enterocolitis had increased fecal calprotectin concentrations, and there was a correlation between calprotectin concentrations and severity of NEC.
CONCLUSIONS: We concluded that fecal calprotectin is a useful marker for diagnosis and severity of NEC in preterm infants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997988

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  15 in total

Review 1.  Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature.

Authors:  Vasilios Pergialiotis; Panagiotis Konstantopoulos; Nikoleta Karampetsou; Diamanto Koutaki; Eleana Gkioka; Despina N Perrea; Nikolaos Papantoniou
Journal:  Inflamm Res       Date:  2016-06-21       Impact factor: 4.575

Review 2.  New insights into necrotizing enterocolitis: From laboratory observation to personalized prevention and treatment.

Authors:  David J Hackam; Chhinder P Sodhi; Misty Good
Journal:  J Pediatr Surg       Date:  2018-06-18       Impact factor: 2.545

3.  Elevated fecal calprotectin levels during necrotizing enterocolitis are associated with activated neutrophils extruding neutrophil extracellular traps.

Authors:  B C MacQueen; R D Christensen; C C Yost; D K Lambert; V L Baer; M J Sheffield; P V Gordon; M J Cody; E Gerday; R Schlaberg; J Lowe; J G Shepherd
Journal:  J Perinatol       Date:  2016-07-07       Impact factor: 2.521

4.  Necrotizing enterocolitis in preterm newborn with a history of maternal COVID-19: a case report.

Authors:  Rennilia Nita; Fendy Matulatan
Journal:  Radiol Case Rep       Date:  2022-05-28

5.  Relationships of Feeding and Mother's Own Milk with Fecal Calprotectin Levels in Preterm Infants.

Authors:  Maureen Groer; Terri Ashmeade; Adetola Louis-Jacques; Jason Beckstead; Ming Ji
Journal:  Breastfeed Med       Date:  2016-03-22       Impact factor: 1.817

6.  Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch-Schonlein purpura in children.

Authors:  Xu Teng; Cuiyun Gao; Mei Sun; Jie Wu
Journal:  Clin Rheumatol       Date:  2017-10-10       Impact factor: 2.980

Review 7.  Calprotectin: Clinical Applications in Pediatrics.

Authors:  Oscar R Herrera; Michael L Christensen; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jul-Aug

Review 8.  The role of calprotectin in pediatric disease.

Authors:  George Vaos; Ioannis D Kostakis; Nick Zavras; Athanasios Chatzemichael
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

9.  The Mean Platelet Volume Combined with Procalcitonin as an Early Accessible Marker Helps to Predict the Severity of Necrotizing Enterocolitis in Preterm Infants.

Authors:  Na Cai; Wei Liao; Zhiqiang Chen; Min Tao; Sheng Chen
Journal:  Int J Gen Med       Date:  2022-04-08

10.  CD16+CD163+ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants.

Authors:  Oluwabunmi O Olaloye; Peng Liu; Jessica M Toothaker; Blake T McCourt; Collin C McCourt; Jenny Xiao; Erica Prochaska; Spenser Shaffer; Lael Werner; Jordan Gringauz; Misty Good; Jeffrey D Goldsmith; Xiaojing An; Fujing Wang; Scott B Snapper; Dror Shouval; Kong Chen; George Tseng; Liza Konnikova
Journal:  J Exp Med       Date:  2021-07-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.